Opicapone for the treatment of early wearing-off in levodopa-treated Parkinson&#39;s disease: pooled analysis of patient level data from two randomized open-label studies.

Ongentys (opicapone) - Ono Pharma, Neurocrine, BIAL

http://www.ncbi.nlm.nih.gov/pubmed/39164557

; Angelo Antonini; Beomseok Jeon; Daniela M Rodrigues; Fabrizio Stocchi; Guillermo Castilla-Fernández; Hyeo-Il Ma; Jee-Young Lee; Joaquim J Ferreira; Joerg Holenz; José-Francisco Rocha; Miguel M Fonseca; Olivier Rascol; Werner Poewe

Aug 21, 2024